Mia Wadelius
Department of Medical Sciences
Clinical Pharmacology
Uppsala University
Uppsala University Hospital
Sweden
Name/email consistency: high
- Pharmacogenomics and personalized medicine: the plunge into next-generation sequencing. Wadelius, M., Alfirevic, A. Genome. Med (2011)
- Point: use of pharmacogenetics in guiding treatment with warfarin. Wadelius, M. Clin. Chem. (2009)
- Pharmacogenetics of warfarin: current status and future challenges. Wadelius, M., Pirmohamed, M. Pharmacogenomics J. (2007)
- Common VKORC1 and GGCX polymorphisms associated with warfarin dose. Wadelius, M., Chen, L.Y., Downes, K., Ghori, J., Hunt, S., Eriksson, N., Wallerman, O., Melhus, H., Wadelius, C., Bentley, D., Deloukas, P. Pharmacogenomics J. (2005)
- Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors. Wadelius, M., Sörlin, K., Wallerman, O., Karlsson, J., Yue, Q.Y., Magnusson, P.K., Wadelius, C., Melhus, H. Pharmacogenomics J. (2004)









